Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kathryn E. Beckermann, Douglas B. Johnson & Jeffrey A. Sosman. (2017) PD-1/PD-L1 blockade in renal cell cancer. Expert Review of Clinical Immunology 13:1, pages 77-84.
Read now
Read now
Pierre Combe, Eleonore de Guillebon, Constance Thibault, Clémence Granier, Eric Tartour & Stéphane Oudard. (2015) Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma. OncoImmunology 4:5.
Read now
Read now
Katharina Geissler, Paolo Fornara, Christine Lautenschläger, Hans-Jürgen Holzhausen, Barbara Seliger & Dagmar Riemann. (2015) Immune signature of tumor infiltrating immune cells in renal cancer. OncoImmunology 4:1.
Read now
Read now
Articles from other publishers (15)
Rebecca Ibrahim, Khalil Saleh, Claude Chahine, Rita Khoury, Nadine Khalife & Axel Le Cesne. (2023) LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy. Biomedicines 11:7, pages 1878.
Crossref
Crossref
Hansen Lin, Liangmin Fu, Pengju Li, Jiangquan Zhu, Quanhui Xu, Yinghan Wang, Mukhtar Adan Mumin, Xinwei Zhou, Yuhang Chen, Guannan Shu, Gaosheng Yao, Minyu Chen, Jun Lu, Lizhen Zhang, YuJun Liu, Yiqi Zhao, Jiahao Bao, Wei Chen, Junhang Luo, Xiaofei Li, Zhenhua Chen & Jiazheng Cao. (2023) Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma. Journal of Translational Medicine 21:1.
Crossref
Crossref
Joseph A. Vento & Brian I. Rini. (2022) Treatment of Refractory Metastatic Renal Cell Carcinoma. Cancers 14:20, pages 5005.
Crossref
Crossref
Pablo Álvarez Ballesteros, Jesús Chamorro, María San Román-Gil, Javier Pozas, Victoria Gómez Dos Santos, Álvaro Ruiz Granados, Enrique Grande, Teresa Alonso-Gordoa & Javier Molina-Cerrillo. (2021) Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma. Cancers 13:23, pages 5981.
Crossref
Crossref
D Whiting & S Sriprasad. (2019) Molecular biology and targeted therapy in metastatic renal cell carcinoma. Journal of Clinical Urology 13:1, pages 40-49.
Crossref
Crossref
Shanjuan Hong, Qing Yuan, Haizhui Xia, Genzhen Zhu, Yu Feng, Qiang Wang, Zhiyin Zhang, Wei He, Jian Lu, Chen Dong & Ling Ni. (2019) Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy. Protein & Cell 10:11, pages 840-845.
Crossref
Crossref
Andreas Kahlmeyer, Christine Stöhr, Arndt Hartmann, Peter Goebell, Bernd Wullich, Sven Wach, Helge Taubert & Franziska Erlmeier. (2019) Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma. Journal of Clinical Medicine 8:5, pages 743.
Crossref
Crossref
Grazia R. Tundo, Diego Sbardella, Pedro M. Lacal, Grazia Graziani & Stefano Marini. (2019) On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment. Chemotherapy 64:2, pages 62-80.
Crossref
Crossref
Long Long, Xue Zhang, Fuchun Chen, Qi Pan, Pronnaphat Phiphatwatchara, Yuyang Zeng & Honglei Chen. (2018) The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy. Genes & Cancer 9:5-6, pages 176-189.
Crossref
Crossref
Annette Schnell, Christian Schmidl, Wolfgang Herr & Peter Siska. (2018) The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction. Biomedicines 6:1, pages 25.
Crossref
Crossref
Nicolas A. Giraldo, Etienne Becht, Yann Vano, Florent Petitprez, Laetitia Lacroix, Pierre Validire, Rafael Sanchez-Salas, Alexandre Ingels, Stephane Oudard, Audrey Moatti, Benedicte Buttard, Sarah Bourass, Claire Germain, Xavier Cathelineau, Wolf H. Fridman & Catherine Sautès-Fridman. (2017) Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma. Clinical Cancer Research 23:15, pages 4416-4428.
Crossref
Crossref
Lin Feng, Haipeng Qian, Xuexin Yu, Kan Liu, Ting Xiao, Chengli Zhang, Manchao Kuang, Shujun Cheng, Xueji Li, Jinghai Wan & Kaitai Zhang. (2017) Heterogeneity of tumor-infiltrating lymphocytes ascribed to local immune status rather than neoantigens by multi-omics analysis of glioblastoma multiforme. Scientific Reports 7:1.
Crossref
Crossref
Etienne Becht, Nicolas A. Giraldo, Claire Germain, Aurélien de Reyniès, Pierre Laurent-Puig, Jessica Zucman-Rossi, Marie-Caroline Dieu-Nosjean, Catherine Sautès-Fridman & Wolf H. Fridman. 2016. Tumor Immunology. Tumor Immunology
95
190
.
Nicolas A. Giraldo, Etienne Becht, Franck Pagès, Georgios Skliris, Virginie Verkarre, Yann Vano, Arnaud Mejean, Nicolas Saint-Aubert, Laetitia Lacroix, Ivo Natario, Audrey Lupo, Marco Alifano, Diane Damotte, Aurelie Cazes, Frederic Triebel, Gordon J. Freeman, Marie-Caroline Dieu-Nosjean, Stephane Oudard, Wolf H. Fridman & Catherine Sautès-Fridman. (2015) Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer. Clinical Cancer Research 21:13, pages 3031-3040.
Crossref
Crossref
V Baldan, R Griffiths, R E Hawkins & D E Gilham. (2015) Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma. British Journal of Cancer 112:9, pages 1510-1518.
Crossref
Crossref